Frankfurt am Main, Germany

Aimo Kannt

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 7.1

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Dreieich, DE (2015)
  • Frankfurt-am-Main, DE (2007 - 2022)

Company Filing History:


Years Active: 2007-2022

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Aimo Kannt – Innovator in Metabolic Disease Treatments

Introduction

Aimo Kannt, a prolific inventor based in Frankfurt am Main, Germany, has made significant contributions to the field of medical science, particularly in the treatment of metabolic diseases. With a total of nine patents to his name, his work focuses on innovative therapies aimed at addressing conditions such as non-alcoholic fatty liver disease and diabetic complications.

Latest Patents

Among Aimo Kannt's recent inventions are two notable patents. The first patent revolves around GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis. This invention highlights the medical use of specific GLP-1/glucagon receptor agonists for the prevention and treatment of metabolic liver diseases, especially non-alcoholic fatty liver disease (NAFLD), non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH), and associated liver fibrosis.

His second landmark patent introduces substituted 6-(4-hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors. This invention includes pyrazolo[3,4-b]pyridine compounds useful for treating diseases linked to diabetes and its complications, such as diabetic nephropathy, neuropathy, and retinopathy. The compounds are positioned as active ingredients in pharmaceuticals and pharmaceutical compositions designed to address these critical health issues.

Career Highlights

Aimo Kannt has played a pivotal role in advancing research and development within the pharmaceutical industry. He has worked with prominent companies such as Sanofi and Sanofi-Aventis Deutschland GmbH, contributing his expertise to the development of innovative treatment solutions for patients.

Collaborations

Throughout his career, Aimo has collaborated with esteemed colleagues in the field. Notable coworkers include Oliver Plettenburg and Matthias Loehn, with whom he has exchanged ideas and innovations, further enhancing the impact of his work in the medical community.

Conclusion

Aimo Kannt's dedication to innovation and his extensive patent portfolio underscore his commitment to improving treatment outcomes for individuals suffering from metabolic diseases. Through his groundbreaking inventions, he continues to pave the way for advancements in medical therapies, demonstrating the vital role inventors play in healthcare advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…